Prices delayed by at least 15 minutes | Print
Live UK pricing:
British & American Investment Trust PLC (BAF)
ORD SHS #1Open
8.00p
Previous close
8.00p
Trade high
7.20p
Estimated NAV
9.50
Year high
18.00p
Year low
6.00p
Premium / Discount
-15.79%
Market capitalisation
£2.00 mn
Volume
5,000
Dividend yield
–
Ongoing charge
12%
ISIN
GB0000653112
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Before investing please read:
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 08/12/2023 | 15/11/2024 |
| Ex-dividend date | 07/12/2023 | 14/11/2024 |
| Payment date | 21/12/2023 | 05/12/2024 |
| Amount | 1.75p | 1.75p |
Net asset value (NAV)
| Estimated NAV | 9.50 |
|---|---|
| Latest actual NAV | 9.50 |
| Latest actual NAV date | 28 August 2026 |
| 12m average premium/discount | 31.3% |
Top 10 holdings
| Holdings 30/06/2025 | % of assets |
|---|---|
| Geron Corp | 67.73 |
| Lineage Cell Therapeutics Inc | 0.98 |
| Relief Therapeutics (Switzerland) | 0.49 |
| Proteome Science | 0.18 |
| Northwest Biotherapeutics (Usa) | 0.06 |
| Sherborne Invs (Gurnsey) B (Unlisted) | 0.06 |
Investment objective
The policy is to invest predominantly in investment trusts and other leading UK and US-quoted companies to achieve a balance of income and growth.
Morningstar ratingTM
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 12/10/2026 | 04:17:02 | 7.2 | 5,000 | 360.00 |
| 09/10/2026 | 01:53:43 | 7.2 | 2,262 | 162.86 |
| 05/10/2026 | 08:10:09 | 7.2 | 1 | 0.07 |
| 30/09/2026 | 12:53:38 | 7.57 | 5,000 | 378.50 |
| 25/09/2026 | 04:35:22 | 8.75 | 1,185 | 103.69 |